NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $823,000 | +32.3% | 59,876 | +65.0% | 0.00% | 0.0% |
| Q4 2015 | $622,000 | -2.2% | 36,290 | -28.6% | 0.00% | 0.0% |
| Q2 2015 | $636,000 | +3247.4% | 50,800 | +2904.1% | 0.00% | – |
| Q1 2015 | $19,000 | -99.0% | 1,691 | -98.6% | 0.00% | -100.0% |
| Q4 2014 | $1,829,000 | +135.7% | 119,091 | +85.2% | 0.00% | +200.0% |
| Q3 2014 | $776,000 | +42.4% | 64,300 | +26.6% | 0.00% | 0.0% |
| Q2 2014 | $545,000 | +51.0% | 50,800 | +47.1% | 0.00% | 0.0% |
| Q3 2013 | $361,000 | +27.6% | 34,532 | +40.8% | 0.00% | 0.0% |
| Q2 2013 | $283,000 | – | 24,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |